University College Dublin-ko ikertzaileekin lankidetzan egindako argitalpenak (16)

2022

  1. CRABP2 – A novel biomarker for high-risk endometrial cancer

    Gynecologic Oncology, Vol. 167, Núm. 2, pp. 314-322

  2. Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery

    BJS Open, Vol. 6, Núm. 1

2021

  1. Obstructive sleep apnoea in adult patients post-tonsillectomy

    Sleep Medicine, Vol. 78, pp. 189-192

2020

  1. Unique sleep-stage transitions determined by obstructive sleep apnea severity, age and gender

    Journal of Sleep Research, Vol. 29, Núm. 2

2018

  1. Clinical presentation of patients with suspected obstructive sleep apnea and self-reported physician-diagnosed asthma in the ESADA cohort

    Journal of Sleep Research, Vol. 27, Núm. 6

  2. Five-year risk of stroke after TIA or minor ischemic stroke

    New England Journal of Medicine, Vol. 378, Núm. 23, pp. 2182-2190

  3. Prevalence and characteristics of breakthrough cancer pain in an outpatient clinic in a Catalan teaching hospital: Incorporation of the Edmonton Classification System for Cancer pain into the diagnostic algorithm

    BMC Palliative Care, Vol. 17, Núm. 1

2017

  1. The Spanish Adaptation of the Palliative Performance Scale (Version 2) Among Cancer Patients at the End of Life: Psychometric Properties

    Journal of Pain and Symptom Management, Vol. 54, Núm. 4, pp. 570-577.e5

2016

  1. Chronic kidney disease in European patients with obstructive sleep apnea: the ESADA cohort study

    Journal of Sleep Research, Vol. 25, Núm. 6, pp. 739-745

  2. Clinical phenotypes and comorbidity in European sleep apnoea patients

    PLoS ONE, Vol. 11, Núm. 10

2015

  1. Obstructive sleep apnoea syndrome

    Nature Reviews Disease Primers, Vol. 1

2001

  1. BB-10010, an analog of macrophage inflammatory protein-1α, protects murine small intestine against radiation

    Digestive Diseases and Sciences, Vol. 46, Núm. 12, pp. 2608-2614

  2. Diagnostic ultrasound induces change within numbers of cryptal mitotic and apoptotic cells in small intestine

    Life Sciences, Vol. 68, Núm. 13, pp. 1471-1475

2000

  1. Dose-effect relationship of BB-10010/MIP-1 alpha on proliferation in murine small intestinal epithelium: Single and double administration protocols

    Digestive Diseases and Sciences, Vol. 45, Núm. 12, pp. 2306-2312

1999

  1. BB-10010, an analogue of macrophage inflammatory protein-1 alpha, reduces proliferation in murine small-intestinal crypts

    Scandinavian Journal of Gastroenterology, Vol. 34, Núm. 1, pp. 68-72

  2. Cell-cycle perturbations following low-dose X-rays

    Radiography, Vol. 5, Núm. 2, pp. 111-115